paraneoplastic

(redirected from paraneoplastic syndrome)
Also found in: Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.

par·a·ne·o·plas·tic

 (păr′ə-nē′ə-plăs′tĭk)
adj.
Of or relating to a syndrome or other systemic disturbance associated with but not directly related to a primary tumor or its metastases.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
The radiological studies such as the Magnetic Resonance Imaging (MRI) of brain, plain Computed Tomography (CT) scan chest and ultrasound (USG) of abdomen and pelvis showed normal study ruling out any paraneoplastic syndrome. In our case, we started with analgesics and sodium valproate.
Paraneoplastic syndrome (PS), including PP, is characterized by the following: 1) occurs during the course of a malignancy or precedes it, 2) symptoms do not arise from tumor invasion or compression, and 3) the clinical picture improves with the treatment of the underlying neoplasm (5).
To rule out a paraneoplastic syndrome, an abdominal ultrasonography was performed, which revealed no pathology.
The other postulated explanation is as part of cancer-related paraneoplastic syndrome, which remains to be further elucidated.
NETs can also cause paraneoplastic syndrome because of the secretion of entirely different substances not related to their original cell properties (7).
Malignancy-associated Sweet's syndrome can present as a paraneoplastic syndrome in cancer patients or in patients that have not yet been diagnosed with cancer.
(4) In these cases, it is usually due to metastatic replacement of bone marrow, the toxic effects of chemotherapy on the marrow or platelet consumption by tumoural factors activating disseminated intravascular coagulation, paraneoplastic syndrome including autoimmune thrombocytopenia and idiopathic thrombocytopenic purpura.
Further investigations showed no signs of paraneoplastic syndrome. The TmP-GFR was also compatible with a phosphate loss in urine.
Their topics include non-small cell lung cancer, gastrointestinal stromal tumors, sarcomas and malignancies of the bone, oncological emergencies and paraneoplastic syndrome, and basic principles of radiation oncology.
To exclude a cerebellar paraneoplastic syndrome and viral or autoimmune encephalitis, a lumbar puncture was performed.
Paraneoplastic syndrome refers to signs and symptoms that are found in the presence of a malignancy but are not attributable to direct compression or invasion of the tumor.
A paraneoplastic syndrome may be the initial clinical presentation of RCC in a significant number of patients, and recognition of these syndromes may facilitate early diagnosis.